(Q34240771)

31 July 2017

1 reference

title

Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis (English)

1 reference

31 July 2017

0 references

2

Emery P

0 references

author name string

Alldred A

series ordinal

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

125-137

1 reference

The progression of erosion and joint space narrowing scores in rheumatoid arthritis during the first twenty-five years of disease

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Effects of leflunomide on immune responses and models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Leflunomide interferes with pyrimidine nucleotide biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

The role of T-lymphocytes and cytokines in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Role of cytokines in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

Innovative treatment approaches for rheumatoid arthritis. Cyclosporin, leflunomide and nitrogen mustard

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.1.125

21 January 2018

Identifiers

DOI

10.1517/14656566.2.1.125

1 reference

Dimensions Publication ID

31 July 2017

1011081553

0 references

Fatcat ID

release_jlkjffmjazh45a62x4rb5qppcu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jlkjffmjazh45a62x4rb5qppcu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference